ACC 2022 Conference Coverage
ACC 2022: Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy - Results of the VALOR-HCM Trial
By
ACC 2022 Conference Coverage
FEATURING
Milind Desai
By
ACC 2022 Conference Coverage
FEATURING
Milind Desai
Login to view comments.
Click here to Login